Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Inflammatory mediators in diabetic retinopathy

Publiceringsår: 2010
Språk: Engelska
Publikation/Tidskrift/Serie: Lund University, Faculty of Medicine Doctoral Dissertation Series
Volym: 2010:1
Dokumenttyp: Doktorsavhandling
Förlag: Faculty of Medicine, Lund University


Diabetic retinopathy (DR) is the most feared complication of diabetes with an overall prevalence of 21.9-36.8% and may, if untreated, lead to severe visual disability or blindness. DR is histologically characterized by pericyte and endothelial cell loss, formation of acellular vessel strands, micro-occlusions, progressive ischemia, and finally the appearance of neovascularization and fibrosis. Hyperglycemia in the retina activates pro-inflammatory pathogenetic pathways i.e., the polyol, PKC, hexosamine, and RAS pathways, as well as AGE formation. Molecular changes result in blood flow alterations, formation of reactive oxygen species and oxidative stress, induction of inflammatory signaling systems and inflow of leukocytes, and ultimately altered gene transcription, in turn promoting the biomolecular DR characteristics. This thesis enlightens how established pathways may contribute to inflammation in DR and summarizes the results of five studies. Up-regulation of inflammatory mediators and leukocyte adhesion molecules was demonstrated in serum and eyes of diabetic subjects with both proliferative DR and no or non-proliferative DR in humans. The roles of oxidative stress as well as of inflammation in retinal ischemia-reperfusion were assessed in rats with and without diabetes, while retinal endothelial expression of VCAM-1 and leukocyte accumulation were studied in early diabetes in mice. Dyslipidemia and the anti-inflammatory effects of lipid-modulating compounds as well as an immunoregulating role of TNF-α were also analyzed. These studies support that inflammation, which might be aggravated by dyslipidemia, has a role in early as well as late stages of DR.


MFC Jubileumsaulan, Malmö University Hospital, Entrance 59
  • Anders Kvanta (Docent)


  • Ophthalmology
  • Endocrinology and Diabetes
  • inflammation
  • dyslipidemia
  • diabetic retinopathy
  • oxidative stress
  • TNF-alpha
  • VCAM-1


  • Ophthalmology (Malmö)
  • Elisabet Agardh
  • Carl-David Agardh
  • ISSN: 1652-8220
  • ISBN: 978-91-86443-15-3

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen